Literature DB >> 22661173

Zinc deficiency induces behavioral alterations in the tail suspension test in mice. Effect of antidepressants.

Katarzyna Młyniec1, Gabriel Nowak.   

Abstract

BACKGROUND: Recently, experimental zinc deficiency has been correlated with depression-like alterations in rodents.
METHODS: In the first part of present study, the time course of zinc deficient diet induced alterations in the tail suspension test (TST) in mice was investigated. In the second part, the effect of imipramine and escitalopram in control and zinc-deprived for 3 weeks mice was examined in the TST.
RESULTS: A4- and 10-week administration of a Zn-deficient diet enhanced the immobility time in the TST (by 20% and 57%, respectively). By contrast, a 2-week period of a zinc deficient diet effected the reduction (by 24%) of the immobility time. Moreover, a 2- and 4-week (but not 10-week) of a Zn-deficient diet resulted in the reduction of the body weight (by 37% and 18%, respectively). These results indicate the developing response to zinc deficiency induced by a zinc-deficient diet. The antidepressant-like effect (reduction in the immobility time) of both drugs was significantly reduced in zinc-deprived mice, which suggests treatment-resistance induced by zinc deprivation.
CONCLUSION: Zinc deprivation induces "pro-depressive" behavior and alters antidepressant efficacy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22661173     DOI: 10.1016/s1734-1140(12)70762-4

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  21 in total

1.  Peripheral zinc and neopterin concentrations are associated with mood severity in bipolar disorder in a gender-specific manner.

Authors:  Caitlin E Millett; Dahlia Mukherjee; Aubrey Reider; Adem Can; Maureen Groer; Dietmar Fuchs; Teodor T Postolache; Shannon L Kelleher; Erika F H Saunders
Journal:  Psychiatry Res       Date:  2017-05-17       Impact factor: 3.222

2.  Zinc transporters protein level in postmortem brain of depressed subjects and suicide victims.

Authors:  Anna Rafalo-Ulinska; Joanna Piotrowska; Agata Kryczyk; Włodzimierz Opoka; Magdalena Sowa-Kucma; Paulina Misztak; Grazyna Rajkowska; Craig A Stockmeier; Wojciech Datka; Gabriel Nowak; Bernadeta Szewczyk
Journal:  J Psychiatr Res       Date:  2016-09-13       Impact factor: 4.791

Review 3.  Interaction between Zinc, GPR39, BDNF and Neuropeptides in Depression.

Authors:  Katarzyna Mlyniec
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

4.  Zinc homeostasis and neurodegenerative disorders.

Authors:  Bernadeta Szewczyk
Journal:  Front Aging Neurosci       Date:  2013-07-19       Impact factor: 5.750

Review 5.  Behavioral impairments in animal models for zinc deficiency.

Authors:  Simone Hagmeyer; Jasmin Carmen Haderspeck; Andreas Martin Grabrucker
Journal:  Front Behav Neurosci       Date:  2015-01-06       Impact factor: 3.558

6.  GPR39 (zinc receptor) knockout mice exhibit depression-like behavior and CREB/BDNF down-regulation in the hippocampus.

Authors:  Katarzyna Młyniec; Bogusława Budziszewska; Birgitte Holst; Beata Ostachowicz; Gabriel Nowak
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

7.  Pattern of c-Fos expression induced by tail suspension test in the mouse brain.

Authors:  Kentaro Hiraoka; Keisuke Motomura; Satoru Yanagida; Ayako Ohashi; Nozomi Ishisaka-Furuno; Shigenobu Kanba
Journal:  Heliyon       Date:  2017-06-02

8.  Zinc deficiency is common in several psychiatric disorders.

Authors:  Ole Grønli; Jan Magnus Kvamme; Oddgeir Friborg; Rolf Wynn
Journal:  PLoS One       Date:  2013-12-19       Impact factor: 3.240

9.  Biological consequences of zinc deficiency in the pathomechanisms of selected diseases.

Authors:  Kamil Jurowski; Bernadeta Szewczyk; Gabriel Nowak; Wojciech Piekoszewski
Journal:  J Biol Inorg Chem       Date:  2014-04-19       Impact factor: 3.358

Review 10.  Zinc in the Glutamatergic Theory of Depression.

Authors:  Katarzyna Mlyniec
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.